Librede is one of four companies with a cannabinoid biosynthesis patent disclosing synthesizing cannabinoids in microorganisms from sugars. On January 15, Lygos acquired Librede to accelerate their production of cannabinoids for consumer, nutraceutical, and pharmaceutical products.
Lygos is a biosynthetics company focused on creating high-value molecules from low-cost sugars using biological techniques.
Magic Number published an article about cannabinoid biosynthesis highlighting the main players in the space with secured assets, including Librede, among others, over a week before the acquisition.
At Magic Number, we specialize in tracking and analyzing emerging market sectors from an intellectual property viewpoint. Contact us for a demo of our proprietary Patent Forecast technology which can help you make well-informed market decisions.
